View More Recent Stories
-
BeiGene Ltd. (ONC) PT Raised to $348 at Citizens JMP
-
BeiGene Ltd. (ONC) PT Raised to $334 at TD Cowen
-
BeiGene Ltd. (ONC) PT Raised to $308 at Jefferies
-
BeiGene, Ltd. (ONC) Tops Q4 EPS by 77c, provides guidance
-
Regulatory Approval Clears Path for Oncolytics Biotech (ONCY) to Advance Promising Pancreatic Cancer Treatment, Following a Review of Safety Data
-
Oncolytics Biotech (ONCY) Announces Key Progress and Upcoming Studies for Breast and Pancreatic Cancer Treatments, Prepares for FDA Accelerated Approval Path
-
Oncolytics Biotech (ONCY) Reports Favorable Results for BRACELET-1 Breast Cancer Study Reinforcing Path to Funding of a Registration-Enabling Study
